Involvement of hydrogen sulfide in the progression of renal fibrosis

Yu Wang1, Qi-Qi Xing2, Jing-Ke Tu3

  • 1Reproductive Medicine Center, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

Chinese Medical Journal
|December 20, 2019
PubMed
Abstract

Insights

Hydrogen sulfide (H2S) shows promise in treating kidney fibrosis by reducing inflammation and oxidative stress. Further research is needed to explore its clinical application for protecting renal function.

Area of Science:

  • Nephrology
  • Biochemistry
  • Pharmacology

Background:

  • Renal fibrosis is a hallmark of chronic kidney disease (CKD) with limited curative treatments.
  • Novel therapeutic strategies are urgently needed to combat the progression of renal fibrosis.
  • Hydrogen sulfide (H2S) is an endogenous gas signaling molecule with diverse biological functions.

Purpose of the Study:

  • To review the mechanisms by which H2S exerts therapeutic effects against renal fibrosis.
  • To highlight the potential of H2S as a novel therapeutic agent for renal fibrosis.
  • To discuss the future clinical applications of H2S in treating kidney diseases.

Main Methods:

  • A comprehensive literature search was conducted using PubMed up to February 2019.
  • Keywords included "Hydrogen sulfide," "Chronic kidney disease," "Renal interstitial fibrosis," and related terms.
  • Relevant articles and their bibliographies were systematically reviewed.

Main Results:

  • H2S suppresses inflammation and oxidative stress in renal pathologies.
  • H2S inhibits fibrosis-related cell activation and cytokine expression.
  • H2S ameliorates vascular remodeling, reduces apoptosis, and promotes tubular cell regeneration.

Conclusions:

  • H2S demonstrates significant potential as an alternative or additional therapy for renal fibrosis.
  • H2S may delay the progression of renal fibrosis and protect kidney function.
  • Further research is warranted to elucidate the precise role of H2S and its clinical utility.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
222
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
849
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
1.4K